Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Booster Vaccines Safe in Children on Immunosuppressive Drugs

Key clinical point: Based on retrospective data, live vaccines appear to be safe in children with rheumatic diseases on immunosuppressive therapy.

Major finding: In 234 patients with a spectrum of rheumatic diseases, there were no serious adverse events associated with live booster vaccines.

Data Source: Retrospective multicenter analysis.

Disclosures: Dr. Moshe reported no relevant financial disclosures.